nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—dilated cardiomyopathy	0.126	0.133	CbGpPWpGaD
Balsalazide—Aminohippurate—SLC22A5—dilated cardiomyopathy	0.0536	1	CrCbGaD
Balsalazide—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.0433	0.0457	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.0422	0.0445	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.0329	0.0347	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.0322	0.034	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0268	0.0283	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.0245	0.0258	CbGpPWpGaD
Balsalazide—ALOX5—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0231	0.0244	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.0222	0.0234	CbGpPWpGaD
Balsalazide—PPARG—Noncanonical Wnt signaling pathway—RAC1—dilated cardiomyopathy	0.0187	0.0198	CbGpPWpGaD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—GJA1—dilated cardiomyopathy	0.0167	0.0176	CbGpPWpGaD
Balsalazide—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.0158	0.0167	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.0154	0.0162	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0147	0.0155	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0143	0.0151	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.0139	0.0146	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0134	0.0142	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—ZIC3—dilated cardiomyopathy	0.013	0.0138	CbGpPWpGaD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—RAC1—dilated cardiomyopathy	0.0127	0.0134	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.0119	0.0126	CbGpPWpGaD
Balsalazide—PPARG—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.0109	0.0116	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—LMNA—dilated cardiomyopathy	0.0106	0.0113	CbGpPWpGaD
Balsalazide—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.01	0.0106	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00989	0.0104	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00984	0.0104	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00957	0.0101	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00883	0.00933	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00862	0.0091	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0083	0.00877	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00826	0.00873	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00815	0.00861	CbGpPWpGaD
Balsalazide—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00794	0.00839	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.0077	0.00814	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.0074	0.00782	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00728	0.00769	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00724	0.00765	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—RAF1—dilated cardiomyopathy	0.00695	0.00735	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00684	0.00723	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00667	0.00704	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00666	0.00704	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00652	0.00689	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00647	0.00684	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00636	0.00672	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00635	0.00671	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—FAS—dilated cardiomyopathy	0.00622	0.00657	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00619	0.00654	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.00597	0.00631	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00583	0.00616	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—AGT—dilated cardiomyopathy	0.00583	0.00616	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00582	0.00615	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.00567	0.00599	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.0054	0.00571	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00529	0.00559	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00516	0.00546	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00505	0.00533	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00499	0.00527	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00491	0.00519	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00481	0.00508	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00462	0.00488	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00457	0.00483	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00449	0.00475	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00439	0.00464	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.00433	0.00458	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00417	0.0044	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.00402	0.00424	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ANKRD1—dilated cardiomyopathy	0.00393	0.00416	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TAZ—dilated cardiomyopathy	0.0037	0.00391	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00366	0.00387	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.00354	0.00374	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—NR3C2—dilated cardiomyopathy	0.00351	0.0037	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00337	0.00356	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—SDHA—dilated cardiomyopathy	0.00334	0.00353	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.0033	0.00348	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00321	0.00339	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.00315	0.00333	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00289	0.00305	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00275	0.00291	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	0.00264	0.00279	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00264	0.00279	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00261	0.00276	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.00259	0.00274	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00254	0.00269	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00253	0.00267	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00249	0.00263	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.00234	0.00247	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	0.00222	0.00235	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	0.0022	0.00233	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00219	0.00231	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	0.0021	0.00221	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.00206	0.00217	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00204	0.00216	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00201	0.00212	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00199	0.0021	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.00186	0.00196	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00179	0.00189	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.00167	0.00176	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00165	0.00175	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.00159	0.00168	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	0.00147	0.00155	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CD36—dilated cardiomyopathy	0.00143	0.00151	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00143	0.00151	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00139	0.00147	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	0.00139	0.00147	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AGT—dilated cardiomyopathy	0.00129	0.00136	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00125	0.00132	CbGpPWpGaD
Balsalazide—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.00114	0.0012	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00113	0.0012	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00113	0.0012	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.0011	0.00117	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.0011	0.00116	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00108	0.00114	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000995	0.00105	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	0.000953	0.00101	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GPX1—dilated cardiomyopathy	0.000908	0.00096	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	0.000908	0.000959	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CD36—dilated cardiomyopathy	0.000885	0.000935	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AGT—dilated cardiomyopathy	0.000796	0.000842	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000636	0.000672	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.00062	0.000655	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000558	0.00059	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RAC1—dilated cardiomyopathy	0.000554	0.000585	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	0.000505	0.000534	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CD36—dilated cardiomyopathy	0.000492	0.00052	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AGT—dilated cardiomyopathy	0.000443	0.000468	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RAF1—dilated cardiomyopathy	0.000367	0.000388	CbGpPWpGaD
Balsalazide—PTGS2—Disease—EGFR—dilated cardiomyopathy	0.000252	0.000266	CbGpPWpGaD
